002923.SZ
润都股份
SZSE · Healthcare · C 制造业 · CN
CNY 10.88
−3.55%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
40.2x
Market Cap
CNY 3.64B
MomentumView details →
1D Return
−3.55%
YTD Return
−8.56%
RSI (14)
50.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
40.2x
Market Cap
CNY 3.64B
RSI (14)
50.3
MomentumView details →
1D Return
−3.55%
YTD Return
−8.56%
Similar companies
Latest newsMore news →
Rundu Pharmaceutical received approval from the National Medical Products Administration for its Levamlodipine Besylate API, used to treat hypertension and angina pectoris.5d agoRundu Pharmaceutical received approval from China's National Medical Products Administration for its chemical API (levamlodipine besylate) marketing application in August 2026.5d ago